158 related articles for article (PubMed ID: 32103715)
1. Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity.
Buravchenko GI; Scherbakov AM; Korlukov AА; Dorovatovskii PV; Shchekotikhin AE
Curr Org Synth; 2020; 17(1):29-39. PubMed ID: 32103715
[TBL] [Abstract][Full Text] [Related]
2. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
3. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cells.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Monzote L; Shchekotikhin AE
RSC Adv; 2021 Nov; 11(61):38782-38795. PubMed ID: 35493230
[TBL] [Abstract][Full Text] [Related]
5. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
6. Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells.
Scherbakov AM; Borunov AM; Buravchenko GI; Andreeva OE; Kudryavtsev IA; Dezhenkova LG; Shchekotikhin AE
Cancer Invest; 2018 Mar; 36(3):199-209. PubMed ID: 29624460
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
Hu Y; Xia Q; Shangguan S; Liu X; Hu Y; Sheng R
Molecules; 2012 Aug; 17(8):9683-96. PubMed ID: 22890172
[TBL] [Abstract][Full Text] [Related]
8. [Structure-activity relationships applied to quinoxaline-1,4-dioxides].
Schönfelder D; Stumm G; Bohle M; Niclas HJ
Pharmazie; 1988 Dec; 43(12):837-9. PubMed ID: 3073394
[TBL] [Abstract][Full Text] [Related]
9. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
Urquiola C; Gambino D; Cabrera M; Lavaggi ML; Cerecetto H; González M; de Cerain AL; Monge A; Costa-Filho AJ; Torre MH
J Inorg Biochem; 2008 Jan; 102(1):119-26. PubMed ID: 17804074
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress Modulation and Radiosensitizing Effect of Quinoxaline-1,4-Dioxides Derivatives.
Silva L; Coelho P; Teixeira D; Monteiro A; Pinto G; Soares R; Prudêncio C; Vieira M
Anticancer Agents Med Chem; 2020; 20(1):111-120. PubMed ID: 31746309
[TBL] [Abstract][Full Text] [Related]
14. Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs.
Gali-Muhtasib HU; Haddadin MJ; Rahhal DN; Younes IH
Oncol Rep; 2001; 8(3):679-84. PubMed ID: 11295102
[TBL] [Abstract][Full Text] [Related]
15. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
Rivera G; Andrade-Ochoa S; Romero MSO; Palos I; Monge A; Sanchez-Torres LE
Anticancer Agents Med Chem; 2017; 17(5):682-691. PubMed ID: 27396382
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
[TBL] [Abstract][Full Text] [Related]
17. A new efficient route for the formation of quinoxaline N-oxides and N,N'-dioxides using HOF.CH3CN.
Carmeli M; Rozen S
J Org Chem; 2006 Jul; 71(15):5761-5. PubMed ID: 16839160
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
Solano B; Junnotula V; Marín A; Villar R; Burguete A; Vicente E; Pérez-Silanes S; Aldana I; Monge A; Dutta S; Sarkar U; Gates KS
J Med Chem; 2007 Nov; 50(22):5485-92. PubMed ID: 17910426
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.
Zarranz B; Jaso A; Aldana I; Monge A; Maurel S; Deharo E; Jullian V; Sauvain M
Arzneimittelforschung; 2005; 55(12):754-61. PubMed ID: 16430030
[TBL] [Abstract][Full Text] [Related]
20. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
